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Abstract
Objective
To construct a metric of the impact of brain disorders on people’s lives, based on the psy-
chosocial difficulties (PSDs) that are experienced in common across brain disorders.
Study Design
Psychometric study using data from a cross-sectional study with a convenience sample of
722 persons with 9 different brain disorders interviewed in four European countries: Italy,
Poland, Spain and Finland. Questions addressing 64 PSDs were first reduced based on
statistical considerations, patient’s perspective and clinical expertise. Rasch analyses for
polytomous data were also applied.
Setting
In and outpatient settings.
Results
A valid and reliable metric with 24 items was created. The infit of all questions ranged
between 0.7 and 1.3. There were no disordered thresholds. The targeting between item
thresholds and persons’ abilities was good and the person-separation index was 0.92.
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Persons’ abilities were linearly transformed into a more intuitive scale ranging from zero (no
PSDs) to 100 (extreme PSDs).
Conclusion
The metric, called PARADISE 24, is based on the hypothesis of horizontal epidemiology,
which affirms that people with brain disorders commonly experience PSDs. This metric is a
useful tool to carry out cardinal comparisons over time of the magnitude of the psychosocial
impact of brain disorders and between persons and groups in clinical practice and research.
Introduction
The prevalence of mental disorders such as depression, schizophrenia, and substance depen-
dency, and neurological disorders such as dementia, headache and epilepsy—together called
brain disorders—is extremely high. In Europe, for example, a multi-method study has esti-
mated that over 38% of the total EU population (or more than 160 million people) suffer from
at least one of the 27 brain disorders reviewed [1]. The burden of these disorders is also high,
higher even than that of cardiovascular diseases and cancer [2,3]. Given that depression and
dementia are age-related conditions and the highest contributors to the overall burden of brain
disorders, the effect of demographic ageing trends in Europe and other parts of the world will
dramatically increase this burden in the near future. Accordingly, brain disorders have been
put to the forefront of the political and scientific agendas [1,2,4].
Disability-adjusted Life Years (DALYs), the measure used to calculate the burden of disease
in the Global Burden of Disease studies, is a composite of years lost due to premature mortality
and years lived with disability, understood as non-fatal health consequences of diseases.
Although mortality in some brain disorders is moderately high, disability largely accounts for
the burden of these conditions [3,5]. Yet, like all indirect measures, such as “health gap” or
“health expectancy”, DALYs do not use data collected directly from people with health condi-
tions, but rather relies on available population-based mortality and morbidity statistics and are
calculated using disability weights. These weights are derived from evaluations of the extent of
disability that the general public and health professionals attribute to summary descriptions of
the health consequences of each disease at different severity levels [6]. DALYs, therefore, are
only meaningful for comparisons at the population level, where they are important tools for
health-policy development and resource allocation [7].
To understand the true impact of brain disorders on a person’s life, however, it is essential
to collect information directly from people with such disorders. Direct information on this
impact gives clinicians insight into the outcomes of treatment and provides the information
they need to monitor disease processes and treatment management over time. For clinical and
epidemiological researchers, this information is also indispensable to follow population trends
and make cost-effectiveness evaluations, since treatments are only effective if they actually
make a difference to the day-to-day lives of people.
There is, however, no direct measure or metric that captures the impact of brain disorders
on people’s lives and based on which comparisons across brain disorders are possible. As
described in Cieza et al. [8], what has been done so far is to operationalize this impact in terms
of psychosocial difficulties (PSDs), such as sleep and memory problems and difficulties in
maintaining relationships. In addition, support has been shown for the hypothesis of ‘horizon-
tal epidemiology’, namely that a common set of PSDs are experienced across brain disorders.
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For that study, PSDs were defined using the framework of the International Classification of
Functioning, Disability and Health (ICF) [9]. PSDs are impairments in mental functions and
impairments in body functions under nervous-system control, activity limitations and partici-
pation restrictions that result from the interaction of a person with a brain disorder and the
environmental and personal factors.
The question remains whether a direct metric of the impact of brain disorders on people
lives that is operationalized in terms of PSDs can be constructed. A true metric can only be
constructed psychometrically with Item-Response-Theory (IRT) approaches, which enable
information about specific PSDs to be integrated into a single summary score. Clinicians and
researchers can use these scores to monitor change over time and to evaluate the effectiveness
of interventions. If the metric were constructed from PSDs experienced in common across
brain disorders, as we propose in this investigation, it would be possible to compare the impact
of different disorders and the outcomes of interventions across disorders.
The objective of our paper is thus to construct a true metric of the impact of brain disorders
on people’s lives, based on the PSDs that are experienced in common across brain disorders,
the existence of which confirmed the hypothesis of horizontal epidemiology.
Methods
Ethic statement
The study was conducted in conformity with the ethical principles of the EC Research Ethics
Committee and approved by the Ethics Committee of the Ludwig-Maximilian University,
Munich, Germany, which was the coordinating center, as well as by the Ethics Committee of
the Neurological Institute Carlo Besta IRCCS Foundation in Milan, Italy, the Institute of Psy-
chiatry and Neurology in Warsaw, Poland, the teaching hospital La Princesa of the University
of Madrid in Madrid, Spain and the Järvenpää Addiction Hospital in Haarajoki, Finland.
Design and sample
This is a psychometric study using data from a cross-sectional study carried out with a conve-
nience sample of 722 persons with dementia (N = 80), stroke (N = 80), multiple sclerosis (MS)
(N = 80), epilepsy (N = 80), migraine (N = 80), Parkinson0s Disease (PD) (N = 80), depression
(N = 81), schizophrenia (N = 81) or substance dependency (N = 80). 289 were in and 392 out-
patients. Twenty four had other living situation. The data was collected in the scope of the
EU-funded project “Psychosocial fActors Relevant to BrAin DISorders in Europe” (www.
paradiseproject.eu) [8]. Patients were interviewed by a trained clinical researcher using the
PARADISE data collection protocol developed in the project. The original protocol included
64 PSDs and 59 PSDs determinants considered to be common across brain disorders as well as
questions targeting demographic information, age, the impact of comorbidities, and standard
disorder-specific measures routinely used to assess disease severity. Persons with stroke, MS,
epilepsy, migraine and PD were recruited at the Neurological Institute Carlo Besta IRCCS
Foundation in Milan, Italy; persons with dementia and schizophrenia at the Institute of Psychi-
atry and Neurology in Warsaw, Poland; persons with depression at the teaching hospital La
Princesa in Madrid, Spain; and persons with substance-dependency at the Järvenpää Addiction
Hospital in Haarajoki, Finland.
Individuals participating in the study had to meet the following general inclusion criteria:
age 18 years; main diagnosis (according to ICD-10) of one of the disorders listed above; and
the individual had been informed of the purpose and rationale of the study and had signed the
“patient consent form”. The sample is described in detail elsewhere [8].
PARADISE 24
PLOSONE | DOI:10.1371/journal.pone.0132410 July 6, 2015 3 / 15
The original version of the PARADISE data-collection protocol included 64 PSDs and 59
determinants of those PSDs, but only data referring to the 64 PSDs were considered for this
study. All these PSDs had been operationalized with questions from questionnaires, clinical
instruments and national and international health surveys. If no standard question was avail-
able, new questions were developed. The response options were homogenized to be the same
for all PSDs questions, namely “None”, “Mild”, “Moderate”, “Severe”, “Extreme”, “Don’t
know” and “Not applicable”. Don’t know” was included to record the percentage of persons
not able to choose a response option, i.e. was considered a measure of how understandable
questions are; “Not applicable” was included to evaluate how universal questions are to our
sample with brain disorders, i.e. to which percentage of respondents they do not apply. The
protocol also included a section in which patients were asked to mention the up to five PSDs
that were most salient to them.
Data preparation
For this psychometric investigation, the response options “Don’t know” and “Not applicable”
were considered missing values. The percentage of missing values was extremely low (<3.5%)
for all but six PSD. Three PSDs (Libido, Independence in everyday activities, and Caring for
others) with high percentages of “not applicable” or “don’t know” had missing rates between
7.0 and 8.5%, and three PSDs (Driving, Sexual functions, and Education / Work and employ-
ment) had a very high percentage of “not applicable” responses, resulting in missing-value
rates between 21.0 and 41.4%. We did not consider this to be a problem for the analyses
because the estimations carried out with the Rasch model readily deal with missing values [10].
Data analysis
The metric of the impact of brain disorders on people’s lives was developed in two phases.
The objective of the first phase was to reduce the 64 PSDs of the PARADISE data-collection
protocol to a number that makes the metric more feasible for clinical practice and research.
The number of PSDs was reduced by clinicians and researchers working in the field of brain
disorders during a two-day workshop based on the following four criteria:
1. commonly experienced across brain disorders as described in Cieza et al. [8],
2. non-redundant, i.e. do not correlate highly with other PSDs,
3. representing the whole continuum of PSDs according to Rasch analyses [11], and
4. free of Differential Item Functioning (DIF).
Especially in those cases in which a clear selection based on these criteria was not possible,
two additional criteria were taken into account: a) those PSDs which were mentioned by the
patients as the most salient during the interviews were prioritized, and b) the clinical expertise
of the project team was taken into account, and those PSDs considered most relevant for per-
sons with brain disorders from a clinical point of view were also prioritized.
To be able to apply criterion 2, polychoric correlations were estimated [12,13]. This type of
correlation assumes ordinal-response options to be a categorized representation of an underly-
ing continuous variable and estimates the correlation of those underlying continuous variables.
Correlation coefficients of r>0.9 were considered high and an indication of redundancy.
To be able to apply criteria 3 and 4, Rasch analyses for polytomous data (also known as Par-
tial Credit Model) [11,14] were carried out with the 64 PSDs of the PARADISE data-collection
protocol. The Polytomous Rasch Model is an IRT Model based on the assumption that there
is a unidimensional latent construct to be measured and that both persons and items can be
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located along the continuous unidimensional latent construct. Information about the latent
construct is obtained from the persons’ responses to items, e.g. questions with ordinal-response
options from a questionnaire [15]. The model’s calculations lead to information refereeing of
both persons and items. Each person’s so-called ability is obtained, i.e. the location of the per-
son on the continuum. For each item, the so-called item difficulty is obtained, i.e. the location
of the item on the continuum. In addition, item thresholds are available for each item. For an
item with k response options, there are k-1 thresholds. These indicate the location of the latent
trait where the response options of items best discriminate between persons.
Item thresholds and persons’ abilities should reveal good targeting, i.e. the estimated item
thresholds should cover the same range on the continuum as the estimated persons’ abilities
and be evenly distributed in that range. Items with very similar thresholds are considered
redundant, so that one can be deleted without losing information necessary to estimate the per-
sons’ abilities.
Within the framework of the Rasch model, items should work in the same way, irrespective
of the group being assessed, i.e. the difficulty of an item should be the same regardless of e.g.,
gender. Items that violate this criterion exhibit Differential Item Functioning (DIF).
We carried out the Rasch analyses and paid special attention to the results of item difficulty,
i.e. item thresholds (criterion 3), and DIF (criterion 4). Bi-factor analysis was used to verify uni-
dimentionality. In bi-factor analysis an extra factor, i.e., a general factor that loads in all items
is estimated and unidimensionality was considered to be met, if all questions used in the instru-
ment load higher in the general factor than in the specific factors. Prior to bi-factor analyses we
estimated, in a first step, polychoric correlation coefficients for ordered-category data. In a sec-
ond step, Parallel Analysis was carried out in order to decide how many factors should be
retained in the Bi-Factor Analysis. In parallel analysis the eigenvalues resulting from an explor-
atory factor analysis and based on the polychoric correlations of the actual data are compared
to those resulting from simulated data. The number of factors is defined as the number of
eigenvalues from the actual data exceeding those of the simulated data. Bi-factor analysis was
then carried out with this number of factors.
We used the lordif package in R to test for DIF for gender and psychiatric vs. neurologic dis-
orders. This package performs iterative hybrid ordinal logistic regression and uses the persons’
ability parameters as conditioning variable; change in McFadden’s pseudo R-squared measure
(>0.02) was used as the DIF criterion [16,17]. Items not showing DIF were preferred over
items showing DIF wherever possible.
The objective of the second phase was to create a metric of the impact of brain disorders on
people’s lives and to evaluate its psychometric properties based on the selected subset of PSDs.
We again applied Rasch analysis and examined the following properties: item fit, ordering of
the thresholds, targeting between item thresholds and persons’ abilities, DIF and reliability.
Item fit was examined based on the infit mean square statistics. The infit should fall
between 0.7 and 1.3 to indicate good item fit [18]. The ordering of item thresholds was stud-
ied based on the threshold estimates for each PSD. The items’ thresholds should have increas-
ing values. If this was not the case and items’ thresholds were disordered, response options
for those items have to be collapsed as recommended by Andrich 2005 and Linacre 2002
[19,20]. The targeting between item thresholds and persons’ abilities was examined by com-
paring the distribution of persons’ abilities and item thresholds along the latent trait contin-
uum. If both are in the same range of the continuum, the set of items is well targeted. DIF was
tested again for gender and psychiatric vs. neurologic disorders using the same methodology
as described above. Reliability was studied with the Person Separation Index rß, which is
analogous to the traditional test theory indices Kuder-Richardson Formula 21 or Cronbach’s
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alpha and ranges between zero and 1, where the value of 1 indicates perfect reproducibility of
person placements [21].
Finally, persons’ abilities—originally obtained on a logit scale—were linearly transformed to
a more intuitive scale ranging from zero (no PSDs) to 100 (extreme PSDs) [22].
Data analyses were performed in SPSS, SAS and R.
Results
Table 1 summarizes the demographic characteristics and disease severity of the sample.
Bi-Factor analysis was carried out in order to verify the assumption of unidimensionality, a
requirement to apply Rasch Analyses. Estimated polychoric correlation coefficients confirmed
the absence of highly correlated variables (r>0.95) and parallel analysis indicated that the
number of factors in the bi-factor analysis should equal 10. Bi-Factor analysis was therefore
carried out with 10 factors. Factor loadings of the bi-factor analysis with 10 specific factors and
an extra general factor showed that the factor loading on the general factor was consistently
higher than the loading on the specific factors. The assumption of unidimensionality was con-
sidered to be met and Rasch Analysis carried out will all 64 items.
In the first phase, during the two-day workshop and after applying the four above-men-
tioned criteria, the number of PSDs to be considered in the metric of the impact of brain disor-
ders on people’s lives was reduced from 64 to 24. The 64 PSDs are reported in Cieza et al. and a
table including the PSD of the PARADISE data collection protocol and the percentage of per-
sons reporting PSDs by health disorder is available as supplementary file (S1 Table). [8]. The
24 PSDs selected together with the category of the ICF that they represent, as well as the ques-
tion used to operationalize them, are presented in Table 2.
Even though the PSDs addressing specific areas of self-care (Washing oneself, Toileting,
Dressing and Eating) were not frequently experienced across brain disorders (criterion 1)
when considered separately, the participants in the workshop decided that a PSD on general
self-care should be selected. Data on this PSD was generated combining the data of all 4 specific
self-care PSDs and using the highest level of limitation each person reported in all 4. The newly
created PSD called general self-care was experienced across brain disorders according to the
criteria of Cieza et al. [8]. The participants also agreed that the question to be used in future
studies to operationalize general self-care should be “How much difficulty did you have in
grooming or dressing, toileting or eating?”
The participants also made the following recommendations for the questions used to opera-
tionalize the following PSDs based on the data-collection experience:
1. Looking after one’s health: the word ‘prescribed’ should be added to medicines (How much
difficulty did you have with looking after your health, such as eating well, exercising and tak-
ing your prescribed medicines?)
2. Informal relationships with friends: ‘maintaining a friendship’ should be replaced by ‘initiat-
ing and maintaining a friendship’ (How much difficulty did you have in initiating and main-
taining a friendship?)
In the second phase, an initial Rasch model with the questions operationalizing the 24
PSDs selected in the first phase was calculated. Twelve questions presented disordered thresh-
olds, and one item ‘How much difficulty did you have in walking a long distance, such as a kilo-
metre (or equivalent)?’ presented DIF for neurological/psychiatric conditions.
With respect to the disordered thresholds, we decided to reduce the number of response
options from 5 to 3 using the collapsing strategy 01122 for all questions (Mild collapsed with
Moderate and Severe with Extreme). This decision was not only made based on a) the large
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number of questions with disordered thresholds, b) the frequencies of the response options
and c) which response options presented disordered thresholds, but also on the fact that any
measure is much more feasible and easier to fill in when all questions have the same response
options.
With respect to the DIF of the question on walking, we had two options: delete the item, or
split the item calculating its difficulty separately for neurological and psychiatric conditions.
Deleting was not an option because this question was the only one directly addressing
Table 1. Demographic characteristics of the sample.
Epilepsy Migraine Multiple
Sclerosis
Parkinson Stroke Dementia Depression Schizophrenia Substance
Dependency
N 80 80 80 80 80 80 81 81 80
Age
(years)
Mean 41,23 44,54 41,03 61,24 59,84 81,03 54,81 38,38 39,56
SD 11,99 12,12 8,74 10,45 14,36 5,49 14,73 14,03 13,15
Gender
(%)
Female 50,0% 86,3% 65,0% 40,0% 43,8% 78,8% 82,7% 53,1% 37,5%
General
living
situation
(%)
Living
independently
and alone
11,3% 12,5% 15,0% 13,8% 10,0% 25,0% 34,6% 23,5% 41,3%
Living
independently
with others in a
household
88,8% 87,5% 83,8% 86,3% 83,8% 55,0% 59,3% 65,4% 42,5%
Persons
working
(%)
66,3% 67,5% 72,5% 33,8% 25,0% 0,0% 27,2% 8,6% 6,3%
Disease
duration
(years)
Mean 18,67 21,13 7,66 6,26 4,00 3,69 12,63 13,03 12,16
SD 12,32 14,60 6,94 4,40 6,48 2,70 11,57 11,83 8,67
Disease
severity
Instrument* CRS MIDAS EDSS Hoehn &
Yahr
NIHSS MMSE HDRS CGI ADS**
N 79 80 80 80 55 80 81 81 34
Mean (SD) na 27,16
(22,92)
2,13
(1,74)
na 4,93
(4,39)
21,10
(2,89)
19,70 (5,49) na
Cut-off Mild
Severity
= 1 <6 <3 = 1 or 1.5 1 to 5 25 <14 = 2 or 3  13
No of persons 24 9 64 15 37 6 11 32 1
Cut-off
Moderate
Severity
= 2  6 & 
20
 3 &  5 = 2 or 2.5 6 to 14  10 & <
25
 14 & 
18
= 4 or 5  14 &  21
No of persons 28 27 9 58 14 74 26 49 7
Cut-off High
Severity
= 3 >20 > 5 = 3 or 4  15 < 10 >18 = 6 or 7  22
No of persons 27 44 7 7 29 0 44 0 26
* HDRS: Hamilton Depression Rating Scale; CRS: Clinical Rating of Severity; MIDAS: Migraine Disability Assessment; EDSS: Expanded Disability Status
Scale; Hoehn & Yahr: Hoehn & Yahr Score; NIHSS: National Institutes of Health Stroke Scale; CGI: Clinical Global Impression (CGI); MMSE: Mini Mental
State Examination; ADS: Alcohol Dependence Scale.
** In substance dependency, 44 persons had alcohol dependence as their main diagnosis. The data reported here refer to the 34 of those from whom the
ADS data were available. Mean is not reported because of the low N. For all other substance dependency conditions, the intention was to collect data with
the ‘Severity of Dependence Scale’. There were, however, a larger number missing data and the results are, therefore, not reported.
doi:10.1371/journal.pone.0132410.t001
PARADISE 24
PLOSONE | DOI:10.1371/journal.pone.0132410 July 6, 2015 7 / 15
Table 2. Item characteristics resulting from the final Raschmodel: infit statistics, item location, and item thresholds.
ICF Code PSD Name Question Inﬁt Location Threshold
1
Threshold
2
Mental functions
b130 Energy and drive
functions
How much of a problem did you have due to not feeling
rested and refreshed during the day (e.g. feeling tired, not
having energy)?
0.849 -0.829 -2.545 0.888
b1301 Motivation How much of a problem did you have not ﬁnding things that
kept you interested and motivated?
0.814 -0.067 -0.966 0.832
b1302 Appetite How much of a problem did you have with your appetite? 1.067 0.848 0.379 1.317
b134 Sleep functions How much of a problem did you have with sleeping, such
as falling asleep, waking up frequently during the night or
waking up too early in the morning?
1.152 -0.227 -1.201 0.747
b140 Attention functions How much difﬁculty did you have in concentrating on doing
something for ten minutes?
0.871 0.509 -0.523 1.542
b144 Memory functions How much difﬁculty did you have in remembering to do
important things?
1.062 0.115 -1.056 1.286
b147 Psychomotor functions How much of a problem did you have with being slowed
down or feeling as if things were moving too fast around
you?
0.984 0.036 -1.232 1.303
b147 Agitation & Aggression /
Hyperactivity
How much of a problem did you have being so irritable that
you started arguments, shouted at people or even hit
people?
1.124 0.571 -0.250 1.391
b152 Depressive mood How much of a problem did you have with feeling sad, low
or depressed?
0.796 -0.630 -1.886 0.627
b152 Worry and anxiety How much of a problem did you have with worry or
anxiety?
0.912 -0.721 -1.934 0.492
b152 Stress How much of a problem did you have with not being able to
cope with all the things that you had to do?
0.836 -0.228 -1.332 0.876
b164 Executive functions How much difﬁculty did you have in making decisions? 0.834 0.314 -0.569 1.197
Other body functions under central neurological control
b280 Pain How much bodily ache or pain did you have? 1.188 -0.120 -1.229 0.989
b640 Sexual functions How much difﬁculty did you have in sexual activities? 1.131 0.494 0.472 0.515
Difﬁculties in activities and participation
d3 Communication How much difﬁculty did you have in starting and
maintaining a conversation?
1.001 0.912 -0.017 1.841
d450 Walking How much difﬁculty did you have in walking a long distance
such as a kilometre (or equivalent)?
1.257 0.395 -0.175 0.964
d510 + d530
+d540 + d550
Self-care How much difﬁculty did you have in grooming or dressing,
toileting or eating?
0.986 0.936 0.287 1.586
d5 Independency in
everyday activities
How much difﬁculty did you have in staying by yourself for
a few days?
1.075 0.688 0.629 0.747
d570 Looking after one’s
health
How much difﬁculty did you have with looking after your
health, such as eating well, exercising and taking your
medicines?
0.906 0.791 0.270 1.311
d7500 Informal relationships
with friends
How much difﬁculty did you have in maintaining a
friendship?
0.921 0.890 0.243 1.536
d760 + d770 Family relationships and
intimate relationships
How much difﬁculty did you have in getting along with
people who are close to you?
0.935 1.195 0.192 2.199
d839 + d850 Education / Work and
employment
How much difﬁculty did you have in your day-to-day work or
school?
0.992 -0.202 -1.113 0.708
d870 Economic self-sufﬁciency How much difﬁculty did you have with managing your
money?
1.040 0.859 0.247 1.471
d9 Community, social and
civic life
How much difﬁculty did you have in joining in community
activities (for example, festivities, religious or other
activities) in the same way as anyone else can?
0.808 0.220 -0.186 0.625
doi:10.1371/journal.pone.0132410.t002
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difficulties in mobility. Splitting the item was not ideal because it would force us to create two
separate converting tables from the logic scale to a scale from 0 to 100 for neurological and psy-
chiatric conditions. This would reduce the feasibility and the simplicity of the measure. We
therefore decided to keep the question in the measure as it was for the sake of feasibility and
simplicity, accepting the arguably small measurement error resulting from this decision.
The Rasch model was calibrated again after collapsing the response options. Table 2 pres-
ents the items’ locations, infit estimates and their thresholds. The infit of all questions ranges
between 0.7 and 1.3, which indicates good item fit. There are no disordered thresholds.
The question on walking still presented DIF for neurological/psychiatric conditions. For the
same reason as before, no further actions were taken to resolve this problem.
The targeting between item thresholds and persons’ abilities is shown in Fig 1. The targeting
is good. The thresholds cover the whole continuum of PSDs with more threshold density in the
higher levels of the continuum (towards a higher degree of difficulties). The person-separation
index was 0.92, which indicates a high reliability and reproducibility of persons’ placements
with the developed metric.
Persons’ abilities were linearly transformed into a more intuitive scale ranging from zero
(no PSDs) to 100 (extreme PSDs). Table 3 presents the assignment of raw scores to persons’
abilities on the logic scale and to metric scores ranging from 0 to 100. This table is an aid for all
users of the developed measure to calculate an intuitive metric score from 0 to 100 of the
impact of brain disorders on people’s lives with which true comparisons over time between
individuals or groups can be made. For everyday use of the metric, the second column regard-
ing persons’ abilities can be omitted.
The final measure presented in the supplementary file (S1 Text) can be used in clinical prac-
tice and research and integrates the rewording of three items proposed by the persons involved
in its development and the newly-created item on self-care.
Discussion
We constructed a valid and reliable metric with which information directly collected from per-
sons with brain disorders can be integrated in a single score to estimate the impact of those dis-
orders on people’s lives. We call this metric PARADISE 24 because it has been developed
within the scope of the EU-funded project “Psychosocial fActors Relevant to BrAin DISorders
in Europe”, that uses the acronym PARADISE. To our knowledge, this is the first such metric
constructed to make comparisons over time and between persons and groups of persons with
different brain disorders.
Our approach is original because it was guided by the hypothesis of horizontal epidemiol-
ogy, namely that there are PSDs experienced in common across brain disorders [8]. The selec-
tion of PSDs and questions to operationalize them was a multi-stage process governed not only
by statistical considerations, but also by the opinions of persons with brain disorders and by
clinical experts working with them. We are confident that the metric properties of the final
measure with 24 questions are very good because of the thorough process with which those
questions were selected and because most of them were from validated instruments and had
already been tested. Our intention was to produce an original tool in terms of the development
process and the scope of applicability, but without repeating the work that other authors have
carried out in the past.
There have been other attempts to capture difficulties in everyday life across brain disorders.
Pukrop and Moeller published a study on the development of a modular system for assessing
the quality of life of persons with psychiatric disorders in 2000 [23]. More recently, Cella et al.
validated 13 brief measures of quality of life, each of which comprises a set of items for persons
PARADISE 24
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Fig 1. Distribution of persons’ abilities, items’ difficulties (bullets) and items’ thresholds (circles) on the latent scale. Legend: The upper part of the
figure displays the distribution of personal abilities, while items’ locations and thresholds are displayed on the lines below. The items are presented according
to their location in increasing order.
doi:10.1371/journal.pone.0132410.g001
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Table 3. Assignment of raw scores, persons’ abilities and transformed scores on a 0–100 scale of the
PARADISE 24metric.
Raw scores Persons' abilities Transformed score
0 -4.898 0
1 -4.065 10
2 -3.303 19
3 -2.832 25
4 -2.481 29
5 -2.196 33
6 -1.955 36
7 -1.743 38
8 -1.554 41
9 -1.382 43
10 -1.223 45
11 -1.076 46
12 -0.938 48
13 -0.807 50
14 -0.683 51
15 -0.565 53
16 -0.452 54
17 -0.343 55
18 -0.237 57
19 -0.135 58
20 -0.035 59
21 0.063 60
22 0.159 61
23 0.254 63
24 0.348 64
25 0.441 65
26 0.534 66
27 0.627 67
28 0.720 68
29 0.815 69
30 0.910 71
31 1.007 72
32 1.107 73
33 1.209 74
34 1.315 76
35 1.424 77
36 1.539 78
37 1.660 80
38 1.793 81
39 1.937 83
40 2.087 85
41 2.242 87
42 2.397 89
43 2.552 91
44 2.707 92
45 2.862 94
(Continued)
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with neurologic disorders [24]. Our metric is different from these efforts for at least three rea-
sons. First, we developed a measure applicable for both psychiatric and neurological condi-
tions; the development of PARADISE 24 was undertaken with persons with 9 brain disorders.
Second, we developed a single metric with which cardinal comparisons can be carried out.
With our metric we could assess whether the psychosocial impact of brain disorders in people’s
lives changes over time and the magnitude of that change. Cardinal comparisons can also be
carried out among different persons or groups of persons. In contrast, if different dimensions
are assessed, it is more difficult to come up with an estimation of the magnitude of the overall
change or the overall difference. Third, PARADISE 24 is a metric of the impact of brain disor-
ders in people’s lives operationalized with PSDs. We capture the extent of actual PSDs and not
a subjective evaluation of whether people are more or less satisfied with those difficulties [25].
Therefore, PARADISE 24 is not a quality of life instrument.
The 24 questions of our metric covering problems and difficulties experienced in 12 mental
functions, 10 activities and participation domains, in pain and in sexual functions proved to
cover the complete severity continuum of PSDs. The question that best differentiates among
people who are at different levels of the continuum is the one capturing energy and drive ‘How
much of a problem did you have due to not feeling rested and refreshed during the day (e.g. feel-
ing tired, not having energy)?’ The questions that differentiate least are those addressing sexual
functions ‘How much difficulty did you have in sexual activities?’ and independence in everyday
life ‘How much difficulty did you have in staying by yourself for a few days?’ The response
thresholds of these two items are very close, indicating that they only differentiate between not
having a difficulty at all and having difficulty irrespective of the magnitude. Based on this
result, we could have dichotomized the response options of both questions without losing mea-
surement precision. We decided, however, to keep them as they were because their thresholds
were not disordered, and we thought that the metric would be easier to use if all questions had
the same number of response options.
Practicability guided several of our decisions in the process of developing PARADISE 24. A
primary goal was to develop a metric for clinical practice and for research. It can be used as an
interview or be directly filled out by the persons with brain disorders, depending on the most
feasible approach in the setting in which it will be used. In clinical practice, PARADISE 24 can
be used as a profile of patient difficulties to guide the planning, follow-up and reporting of
health-care interventions. The use of a profile of PSDs for the assignment of interventions can
be especially useful in a multi-professional team [26]. Since we have demonstrated that the
PARADISE-24 questions capture a single dimension and know the location of those questions
in that dimension based on the analyses of this investigation, a summary score can also be cre-
ated and easily transformed into an intuitive metric scale from 0 to 100 using Table 3. The
summary scores will allow clinicians to estimate patients’ overall PSD levels, to monitor disease
and treatment management and to follow patients along the continuum of care and over their
lifespans. For researchers, PARADISE 24 with its summary score represents an ideal outcome
measure for assessing the effectiveness of interventions. For policy makers, the option of creat-
ing this score based on the PSDs that are relevant to people with brain disorders and the
Table 3. (Continued)
Raw scores Persons' abilities Transformed score
46 3.016 96
47 3.171 98
48 3.326 100
doi:10.1371/journal.pone.0132410.t003
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possibility of making comparisons across disorders make PARADISE 24 a first choice instru-
ment for cost-effectiveness evaluations. Other instruments used for that purpose, such as the
Short Form-36 [27] and the EQ-5D [28] are not appropriate for people with mental disorders
[29,30].
We are aware that clinicians and researchers specialized in specific brain disorders may
miss PSDs they frequently see in their patients. If this is the case, we suggest adding questions
addressing those PSDs to PARADISE 24 to enlarge the profile of PSDs. The use of questions
from existing questionnaires reported in Cieza et al. [8] is highly recommended for this pur-
pose. For the creation of a summary score and for comparisons, however, only the information
in the 24 questions of PARADISE 24 should be considered, since only those questions have
been calibrated in a single metric and are relevant across brain disorders.
Our investigation also has several limitations that should be addressed in future studies.
First, our sample was a convenience sample of persons with brain disorders, and we cannot be
certain about the generalisability of the results. Second, to standardize the data collection the
information to answer the questions was always collected during an interview. Future studies
have to determine whether the psychometric properties of the metric are still good when the
persons with brain disorders fill in the questionnaire themselves. Third, we were not able to
test for DIF by each of the nine conditions separately because the requirement of the procedure
we used is that at least 5 observations per response option of each PSD are available for all
health conditions. This was not met in our sample. To overcome this limitation we tested for
DIF for psychiatric vs. neurologic disorders. Further studies with larger sample sizes should
test for DIF by health conditions. Finally, we did not collected information for at least one part
of the sample at two time points. Therefore, data on the sensitivity to change of the metric are
still missing.
Conclusion
Ametric for the assessment of the impact of brain disorders in people’s lives has been con-
structed for the first time. The metric is called PARADISE 24 and is based on the hypothesis of
horizontal epidemiology, which affirms that people with brain disorders commonly experience
PSDs and which has been confirmed in another investigation [8]. This metric is a useful tool to
carry out cardinal comparisons over time of the magnitude of the psychosocial impact of brain
disorders and between persons and groups in clinical practice and research.
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